A once-in-a-decade opportunity to buy these ASX 200 growth shares before they rocket?

Is now the time to seize on market weakness to buy these highly rated stocks?

| More on:
A group of people in suits watch as a man puts his hand up to take the opportunity.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

I think it is fair to say that the past few weeks have been difficult for investors. Particularly those that invest in ASX 200 growth shares.

The dramatic selloff has seen many shares retreating sharply from their recent highs.

While it is disappointing to see your portfolio shed value, every cloud has a silver lining.

The silver lining here is that it could have created a once-in-a-decade opportunity that investors have been waiting for – a chance to buy quality ASX 200 growth shares at a discount before they rebound and potentially rocket to new highs.

But which growth shares could be worth buying right now? Let's take a look at three that analysts are tipping as buys. They are as follows:

Lovisa Holdings Ltd (ASX: LOV)

The first ASX 200 growth share to consider buying after the selloff is Lovisa. This fashion jewellery retailer's shares have pulled back by over 7% from recent highs.

Analysts at Morgans will see this as a buying opportunity. Following a similar pullback at the end of last year, the broker commented: "Lovisa has proven it can successfully build out its unique brand in many diverse territories around the world on its journey to becoming a truly global brand. It's at times like these that investors should be getting set to reap the rewards of this strategy over the longer term."

Morgans has an add rating and $37.00 price target on its shares.

Pro Medicus Limited (ASX: PME)

Another ASX 200 growth share that was dragged lower during the market selloff is Pro Medicus. It is a leading provider of radiology information systems (RIS), Picture Archiving and Communication Systems (PACS), and advanced visualisation solutions across the globe.

Analysts at Goldman Sachs are likely to see this pullback as a great opportunity for investors to buy this high quality company. Particularly given how the broker sees "PME as the clear incumbent technology leader in a growing market with a strong financial profile and significant AI upside."

It has a buy rating and $148.00 price target on its shares.

Xero Ltd (ASX: XRO)

A final stock that could be a top option for investors is Xero. This leading cloud-based accounting software provider is another ASX 200 growth share that has been caught up in the recent selloff.

However, despite the near-term volatility, Xero's long-term growth prospects remain very bright thanks to the structural shift to the cloud. In fact, Goldman Sachs estimates that it has a total addressable market of 100 million small to medium sized businesses. This compares to its current subscriber base of 4.2 million.

Goldman believes this gives it a multi-decade growth runway. It is no surprise then that it is tipping its shares as a buy with a $180.00 price target.

Motley Fool contributor James Mickleboro has positions in Lovisa, Pro Medicus, and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Lovisa, Pro Medicus, and Xero. The Motley Fool Australia has positions in and has recommended Xero. The Motley Fool Australia has recommended Lovisa and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

a man holds a firework sparkler in both hands as a shower of sparkly confetti falls from the sky around him as he smiles and closes his eyes in a celebratory scene.
Growth Shares

Happy New Year: Here are two ASX stocks to watch going into 2026

Analysts are expecting big things from these shares this year.

Read more »

Two people jump and high five above a city skyline.
Growth Shares

The top ASX growth stocks that could rebound in 2026 after a brutal year

Analysts see potential for these shares to rebound strongly next year.

Read more »

A man and woman sit next to each other looking at each other and feeling excited and surprised after reading good news about their shares on a laptop.
Growth Shares

The Australian stocks I'd trust for the next 10 years

It is no surprise that brokers rate these stocks as buys.

Read more »

A smartly-dressed businesswoman walks outside while making a trade on her mobile phone.
Growth Shares

2 stocks to help turn $100,000 into $1 million

You don’t need moonshots to build wealth.

Read more »

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Growth Shares

10 ASX shares I would buy in 2026

I think these are among the best stocks to buy for an ASX share portfolio in the new year.

Read more »

A man points at a paper as he holds an alarm clock, indicating the ex-dividend date is approaching.
Growth Shares

In 2036, you will be glad you bought these ASX shares today

Want to make long term investments? I think these shares could be top picks.

Read more »

fintech, smart investor, happy investor, technology shares,
Growth Shares

These ASX 200 growth shares could be much bigger in 2035

Want to make buy and hold investments? Analysts think these shares could be top picks.

Read more »

A group of businesspeople clapping.
Growth Shares

These could be 3 of the best ASX stocks to own in 2026

Analysts think these shares are best buys for the year ahead. Let's see what they offer.

Read more »